首页> 外国专利> K14 Antimicrobial peptide isolated from Bacillus amyloliquefaciens K14 and its use in combinatorial drug therapy

K14 Antimicrobial peptide isolated from Bacillus amyloliquefaciens K14 and its use in combinatorial drug therapy

机译:从解淀粉芽孢杆菌K14分离的K14抗菌肽及其在组合药物治疗中的应用

摘要

The present invention relates to a novel Bacillus amyloliquefaciens K14 strain isolated from kimchi, an antimicrobial peptide isolated from the strain, a method for purifying a novel antimicrobial peptide from the strain, and a use of the novel antimicrobial peptide. The antimicrobial peptide (CSpK14) isolated and purified from Bacillus amyloliquefaciens of the present invention not only has a proper antimicrobial effect against MDR pathogens but also CSpK14 significantly increases its activity when it is combined with? -Lactam, Can be usefully used in combination therapies.
机译:本发明涉及从泡菜分离的新的解淀粉芽孢杆菌K14菌株,从该菌株分离的抗菌肽,从该菌株中纯化新的抗菌肽的方法以及该新的抗菌肽的用途。从本发明的解淀粉芽孢杆菌分离纯化的抗菌肽(CSpK14)不仅对MDR病原体具有适当的抗菌作用,而且与之结合使用时,CSpK14的活性也大大提高。 -内酰胺,可以有效地用于联合疗法。

著录项

  • 公开/公告号KR101865782B1

    专利类型

  • 公开/公告日2018-07-04

    原文格式PDF

  • 申请/专利权人 조선대학교산학협력단;

    申请/专利号KR20160157873

  • 发明设计人 유진철;최윤석;최윤희;조승식;

    申请日2016-11-25

  • 分类号C12N1/20;A61K31/397;A61K38/10;C07K1/16;C07K1/30;C07K1/34;C07K7/08;C12R1/07;

  • 国家 KR

  • 入库时间 2022-08-21 12:37:43

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号